What is the recommended antibiotic regimen and dosing for a pediatric patient with a bite wound infection, including alternatives for children under 8 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Treatment for Pediatric Bite Wound Infections

For pediatric bite wound infections, amoxicillin-clavulanate is the first-line oral antibiotic at 45 mg/kg/day divided into 3 doses or 90 mg/kg/day divided into 2 doses, with ampicillin-sulbactam 1.5-3.0 g IV every 6-8 hours as the preferred parenteral option. 1

Primary Recommendation

The IDSA 2014 Skin and Soft Tissue Infection Guidelines explicitly recommend amoxicillin-clavulanate 875/125 mg twice daily for animal bites (adult dosing; pediatric equivalent is 45-90 mg/kg/day of the amoxicillin component) 1. This agent provides coverage against the polymicrobial flora typical of bite wounds, including:

  • Pasteurella multocida (dog and cat bites)
  • Streptococcus species
  • Staphylococcus aureus (especially human bites)
  • Anaerobic bacteria
  • Eikenella corrodens (human bites)

Indications for Prophylactic Antibiotics

Antibiotics should be initiated for 1, 2:

  • Moderate to severe bite wounds
  • Puncture wounds (especially if bone, tendon sheath, or joint penetration)
  • Facial bites
  • Hand or foot bites
  • Genital area bites
  • Wounds requiring primary closure
  • Immunocompromised or asplenic patients
  • Wounds with preexisting or resultant edema

Duration: 3-5 days for prophylaxis; 7-10 days for established infection 1, 2

Alternative Regimens for Children Under 8 Years

For Penicillin-Allergic Patients:

Avoid doxycycline in children under 8 years due to risk of permanent tooth discoloration. Alternatives include:

  1. Clindamycin 30-40 mg/kg/day orally in 3-4 divided doses PLUS a second- or third-generation cephalosporin

    • Clindamycin covers staphylococci, streptococci, and anaerobes but misses Pasteurella multocida 1
    • Add cefuroxime 500 mg twice daily (pediatric: 20-30 mg/kg/day) for Pasteurella coverage
  2. Trimethoprim-sulfamethoxazole (TMP-SMX) 5-10 mg/kg/day of TMP component PLUS metronidazole 7.5 mg/kg every 6 hours

    • TMP-SMX has good aerobic coverage but poor anaerobic activity 1
    • Metronidazole fills the anaerobic gap
  3. Second-generation cephalosporins alone (cefuroxime, cefoxitin)

    • Cefuroxime: good Pasteurella activity but misses anaerobes 1
    • Cefoxitin: better anaerobic coverage

For Severe Infections Requiring IV Therapy:

Ampicillin-sulbactam 50 mg/kg/dose every 6 hours IV (based on ampicillin component) 1

Alternative: Piperacillin-tazobactam 60-75 mg/kg/dose every 6 hours IV (based on piperacillin component) 1

Both regimens miss MRSA—add vancomycin 15 mg/kg every 6 hours IV if MRSA suspected based on local epidemiology or clinical features suggesting staphylococcal infection 1

Critical Pitfalls to Avoid

  1. Do NOT use fluoroquinolones (ciprofloxacin, levofloxacin) in children under 8 years except in life-threatening situations—they have good Pasteurella coverage but risk cartilage damage 1

  2. Clindamycin monotherapy is inadequate for bite wounds because it lacks activity against Pasteurella multocida, a primary pathogen in dog and cat bites 1

  3. First-generation cephalosporins (cephalexin) are inadequate for bite wounds—they lack anaerobic and Pasteurella coverage 1

  4. Penicillin V alone is insufficient for most bite wounds despite older literature suggesting it—it misses beta-lactamase producing organisms and S. aureus 3

Special Considerations

Human Bites:

Higher prevalence of S. aureus and Eikenella corrodens. Amoxicillin-clavulanate remains first-line, but ensure adequate staphylococcal coverage 1, 3

Cat Bites:

Higher risk of deep tissue penetration and Pasteurella infection. More aggressive antibiotic prophylaxis is warranted even for seemingly minor wounds 3

Facial Wounds:

  • Copious irrigation and cautious debridement are essential
  • Primary closure is acceptable for facial wounds (unlike other bite locations) but requires preemptive antibiotics 1
  • Recent data show 99.2% of pediatric facial dog bites receive antibiotics, though adherence to first-line agents and proper dosing varies 4

Adjunctive Management

Beyond antibiotics 1, 2:

  1. Tetanus prophylaxis: Tdap preferred if not previously given; otherwise Td if >10 years since last dose
  2. Rabies prophylaxis: Consult local health officials based on animal type and availability for observation
  3. Wound management: Thorough irrigation, local debridement, avoid primary closure except for facial wounds
  4. Surgical drainage: Required for walled-off abscesses or deep space infections

Monitoring and Follow-up

  • Reassess within 24-48 hours for signs of infection progression
  • If no improvement or worsening despite amoxicillin-clavulanate, consider:
    • MRSA (add vancomycin or clindamycin based on local susceptibility)
    • Atypical organisms (Capnocytophaga canimorsus, Francisella tularensis)
    • Rare pathogens like Mycobacterium fortuitum (requires tNGS for diagnosis and combination therapy with amikacin, linezolid, and doxycycline) 5

The evidence strongly supports amoxicillin-clavulanate as the gold standard for pediatric bite wounds, with clear alternatives for allergic patients that maintain coverage of the polymicrobial flora while avoiding age-inappropriate agents like tetracyclines and fluoroquinolones.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.